Literature DB >> 10209122

Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta.

S Giroux1, M Tremblay, D Bernard, J F Cardin-Girard, S Aubry, L Larouche, S Rousseau, J Huot, J Landry, L Jeannotte, J Charron.   

Abstract

Mek is a dual-specificity kinase that activates the extracellular-signal-regulated (Erk) mitogen-activated protein (MAP) kinases upon agonist binding to receptors. The Erk MAP kinase cascade is involved in cell-fate determination in many organisms. In mammals, this pathway is proposed to regulate cell growth and differentiation. Genetic studies have shown that although a single mek gene is present in Caenorhabditis elegans, Drosophila and Xenopus, two mek homologs, Mek1 and Mek2, are present in the mammalian cascade. In the present study, we describe a mutant mouse line in which the mek1 gene has been disrupted by insertional mutagenesis. The null mutation was recessive lethal, as the homozygous mutant embryos died at 10.5 days of gestation. Histopathological analyses revealed a reduction in vascularization of the placenta that was due to a marked decrease of vascular endothelial cells in the labyrinthine region. The failure to establish a functional placenta probably explains the death of the mek1-/- embryos. Cell-migration assays indicated that mek1-/- fibroblasts could not be induced to migrate by fibronectin, although the levels of Mek2 protein and Erk activation were normal. Re-expression of Mek1 in the mutant mouse embryonic fibroblasts (MEFs) restored their ability to migrate. Our findings provide genetic evidence that establishes the unique role played by Mek1 in signal transduction. They also suggest that mek1 function is required for normal response to angiogenic signals that might promote vascularization of the labyrinthine region of the placenta.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10209122     DOI: 10.1016/s0960-9822(99)80164-x

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  120 in total

Review 1.  Chemical genetics: ligand-based discovery of gene function.

Authors:  B R Stockwell
Journal:  Nat Rev Genet       Date:  2000-11       Impact factor: 53.242

2.  The expression of Akt and ERK1/2 proteins decreased in dexamethasone-induced intrauterine growth restricted rat placental development.

Authors:  Asli Ozmen; Gozde Unek; Dijle Kipmen-Korgun; Emin Turkay Korgun
Journal:  J Mol Histol       Date:  2011-04-23       Impact factor: 2.611

3.  c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma.

Authors:  Rafael B Blasco; Sarah Francoz; David Santamaría; Marta Cañamero; Pierre Dubus; Jean Charron; Manuela Baccarini; Mariano Barbacid
Journal:  Cancer Cell       Date:  2011-04-21       Impact factor: 31.743

4.  Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes.

Authors:  Scott T Eblen; Jill K Slack; Michael J Weber; Andrew D Catling
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

5.  MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts.

Authors:  Bruce D Cuevas; Amy N Abell; James A Witowsky; Toshiaki Yujiri; Nancy Lassignal Johnson; Kamala Kesavan; Marti Ware; Peter L Jones; Scott A Weed; Roberta L DeBiasi; Yoshitomo Oka; Kenneth L Tyler; Gary L Johnson
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

6.  Defective extraembryonic angiogenesis in mice lacking LBP-1a, a member of the grainyhead family of transcription factors.

Authors:  Vishwas Parekh; Amy McEwen; Virginia Barbour; Yutaka Takahashi; Jerold E Rehg; Stephen M Jane; John M Cunningham
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 7.  Opioid receptor trafficking and signaling: what happens after opioid receptor activation?

Authors:  Jia-Ming Bian; Ning Wu; Rui-Bin Su; Jin Li
Journal:  Cell Mol Neurobiol       Date:  2011-09-25       Impact factor: 5.046

8.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

9.  Role of Plk2 (Snk) in mouse development and cell proliferation.

Authors:  Sheng Ma; Jean Charron; Raymond L Erikson
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Loss of SMEK, a novel, conserved protein, suppresses MEK1 null cell polarity, chemotaxis, and gene expression defects.

Authors:  Michelle C Mendoza; Fei Du; Negin Iranfar; Nan Tang; Hui Ma; William F Loomis; Richard A Firtel
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.